Internal Medicine, Infectious Disease · Memphis, TN
NPI
1578530895
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6029 Walnut Grove Rd Ste C002
Memphis, TN, 38120
Phone (901) 685-3490
Groups this clinician bills Medicare through
Medicare paid, 2024
$557K
3,421 services
Medicare patients, 2024
548
Average age 73
Drug cost, 2024
$238K
432 prescriptions
Company payments, 2025
$995
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen C Threlkeld was code 99233 (hospital e&m - subsequent), 618 times for 172 patients. In total Stephen C Threlkeld billed 3,421 services in 46 codes, and Medicare paid $557K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 618 | 172 | $86.69 | $54K |
| 99232 Hospital E&M - Subsequent | Facility | 484 | 179 | $57.18 | $28K |
| 97597 Debridement | Office | 282 | 97 | $66.38 | $19K |
| 99223 Hospital E&M - Initial | Facility | 208 | 193 | $125.53 | $26K |
| 80053 Clinical Chemistry | Office | 180 | 93 | $9.86 | $1,774 |
| 85025 Blood Count | Office | 176 | 93 | $7.24 | $1,274 |
| 86140 Clinical Chemistry | Office | 173 | 91 | $4.83 | $835 |
| 85652 Clinical Chemistry | Office | 170 | 88 | $2.52 | $428 |
| 99214 Office E&M - Established | Office | 131 | 79 | $88.62 | $12K |
| A2001 Innovamatrix ac, per square centimeter | Office | 113 | 14 | $792.07 | $90K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 83 | 44 | $12.17 | $1,010 |
| 36415 Venipuncture Blood Collection | Office | 69 | 48 | $8.65 | $597 |
| 97598 Debridement | Office | 56 | 17 | $30.06 | $1,683 |
| 97140 PT Treatment | Office | 51 | 24 | $17.19 | $877 |
| 29581 Musculoskeletal | Office | 42 | 20 | $77.79 | $3,267 |
By year: 2022 $205K for 2,738 services; 2023 $275K for 4,184 services; 2024 $557K for 3,421 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 180 | 93 | $9.86 | $1,774 |
| 85025 Blood Count | 176 | 93 | $7.24 | $1,274 |
| 86140 Clinical Chemistry | 173 | 91 | $4.83 | $835 |
| 85652 Clinical Chemistry | 170 | 88 | $2.52 | $428 |
| 36415 Venipuncture Blood Collection | 69 | 48 | $8.65 | $597 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen C Threlkeld prescribed most often to Medicare patients was Daptomycin, with 60 prescriptions and refills. In total Stephen C Threlkeld wrote 432 Medicare prescriptions that cost $238K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 60 | 60 | Under 11 | $13K |
| Teflaro Ceftaroline Fosamil Acetate | 35 | 35 | Under 11 | $77K |
| Cefepime Hcl Generic | 35 | 35 | Under 11 | $7,076 |
| Vancomycin Hcl Generic | 25 | 25 | Under 11 | $3,172 |
| Cefdinir Generic | 22 | 26 | 11 | $907 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 22 | 22 | Under 11 | $5,980 |
| Azithromycin Generic | 21 | 21 | Under 11 | $367 |
| Rifampin Generic | 20 | 26 | Under 11 | $1,537 |
| Micafungin Micafungin Sodium | 17 | 17 | Under 11 | $7,756 |
| Ethambutol Hcl Generic | 14 | 14 | Under 11 | $422 |
| Minocycline Hcl Generic | 13 | 14 | Under 11 | $349 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 13 | 13 | Under 11 | $59K |
| Cephalexin Generic | 12 | 12 | Under 11 | $71.34 |
| Ertapenem Ertapenem Sodium | 12 | 12 | Under 11 | $6,105 |
Brand drugs: 67 claims; generic drugs: 365 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen C Threlkeld $995 ($995 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $218.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $218 |
| Gilead Sciences, Inc. GILD | 10 | $199 |
| Abbott Laboratories ABT | 2 | $141 |
| Merck Sharp & Dohme LLC MRK | 5 | $122 |
| Pfizer Inc. PFE | 5 | $93.18 |
| Insmed, Inc. INSM | 4 | $79.35 |
| Astellas Pharma US Inc 4503.T | 2 | $58.91 |
| La Jolla Pharmaceutical Company | 2 | $39.27 |
| Smith+Nephew, Inc. SNN | 1 | $23.25 |
| ViiV Healthcare Company GSK | 1 | $19.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.